LQDA · Liquidia Corp
Market Cap
$5.99B
Shares
89.51M
LQDA metrics
70 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$69.68
Market cap
$5.99B
Price action
19 metricsPrice change (1W)
-5.1%
Price change (30D)
-20.2%
Price change (3M)
+21.4%
Price change (6M)
+110.5%
Price change (YTD)
+94.0%
Price change (1Y)
+141.7%
Trailing year
Price change (5Y)
+2,289.6%
52-week high
$91.03
52-week low
$21.80
Change from 52-week high
-26.5%
Change from 52-week low
+206.9%
Annualized volatility
65.6%
Beta
0.9
RSI (14D)
35.6
Price vs SMA 50
-15.2%
Price vs SMA 200
+31.9%
Avg volume (3M)
1.89M
Relative volume
0.7
Average dollar volume
$141.28M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
89.51M
Valuation
12 metricsP / E (TTM)
47.8
Trailing earnings · reciprocal yield 2.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
13.3×
reciprocal yield 7.5%
P / book
30.7
reciprocal yield 3.3%
FCF yield
2.5%
TTM · current market cap
Buyback yield
—
P / FCF
39.7
reciprocal yield 2.5%
P / operating cash flow
35.7
reciprocal yield 2.8%
Earnings yield
2.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
21.2×
reciprocal yield 4.7%
EV / revenue historical average (5Y)
21.2×
reciprocal yield 4.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
—
Operating margin
37.4%
Trailing 12 months
Net margin
30.7%
Gross profit (TTM)
—
Operating profit (TTM)
$168.57M
Net income (TTM)
$138.61M
Trailing 12 months
Diluted EPS (TTM)
$1.40
FCF margin
33.4%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+1,842.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$450.91M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+18.5%
Year over year · more shares
Revenue CAGR (3Y)
+115.0%
Revenue CAGR (5Y)
+192.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
71.0%
Return on assets
26.6%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
$170.25M
Free cash flow (TTM)
$150.69M
Quick ratio
2.1
Interest coverage
6.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$284.18M
Total assets
$521.92M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$167.71M
Capital expenditures (TTM)
$17.01M
R&D (TTM)
$56.04M
SG&A (TTM)
$192.66M
Stock compensation (TTM)
$34.69M
R&D / revenue
12.4%
Stock compensation / revenue
7.7%
Ownership (13F)
3 metrics13F filers
340
13F filer change QoQ
+89
Institutional ownership
89.3%
Short interest
3 metricsShort interest
13.2%
Latest settlement · 6.5 days to cover
Days to cover
6.5d
Short-squeeze score
63 / 100
Insider activity
2 metricsNet insider buying (90D)
−$120.38M
Insider-sentiment score
11 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1819576
CUSIP
53635D202
13F (30d)
267 filings
264 filers
Visit website
Investor relations